Where does Cagent Vascular, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cagent Vascular, Inc. ranks #12,856 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cagent Vascular, Inc. hold?

Cagent Vascular, Inc. holds 23 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Cagent Vascular, Inc.'s Innovation Score?

Cagent Vascular, Inc. has an Innovation Score of 40.9 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cagent Vascular, Inc.'s patent grant rate increasing or decreasing?

Cagent Vascular, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cagent Vascular, Inc.'s patents?

Cagent Vascular, Inc.'s patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cagent Vascular, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cagent Vascular, Inc.

Q: What technology areas does Cagent Vascular, Inc. focus on?

Cagent Vascular, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 23 patents, ranking #320 of 3,490 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 23 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cagent ranks #12,856 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 10 technology areas.

#12,856
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 20.0
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12856 · US Corporation #12,856 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 23 grants
MID-PACK #12,856/49,997
PHOTO-FINISH Cadwell Laboratories
CPC-FOCUS A61M · 10 areas
INNOV-PAR 40.9/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cadwell Laboratories, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cagent’s 40.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.0 pts (27%) Velocity 6.7 pts (16%) Breadth 11.2 pts (27%) Claim depth 12.0 pts (29%)

Qualcomm Incorporated · highest

85
Cagent Vascular · this assignee

41
3D Lighting… · lowest

7

What this shows Cagent's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cagent?

Each dot is one of Cagent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cagent’s own 20.0 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cagent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cagent's grants concentrate

Cagent Vascular, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2020. By volume, Cagent sits between Creighton University and Cheng Shin Rubber (Xiamen) Ind. Ltd..

Cagent's three-year grant acceleration

Cagent Vascular, Inc. shows 9 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Creighton Univers…

23
Crystal Pharmatech

23
Ctera Networks

23
Cadwell Laborator…

23
Cardica

23
Cequent Consumer…

23
Chemische Fabrik…

23
Cheng Shin Rubber…

23
Cagent Vascular ◀

23

What this shows Cagent holds 23 patents at rank #12,870, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cagent

By rank, the assignees closest to #12,870 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Cagent's primary technology class.

Cagent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cagent Vascular, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	8.7%
2019	3	13.0%
2020	1	4.3%
2021	5	21.7%
2022	6	26.1%
2023	3	13.0%
2025partial year	3	13.0%

Which technologies does Cagent Vascular, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 23

A61B - DIAGNOSIS; SURGERY; Identification 15

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 8

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 7

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 6

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

B23P - Metal-working NOT Otherwise Provided FOR; Combined OPERATIONS; Universal Machine Tools 3

Y10T - Technical Subjects Covered BY Former US Classification 3

C23F - Non-mechanical Removal OF Metallic Material From Surface ; Inhibiting Corrosion OF Metallic Material OR Incrustation IN GENERAL; Multi-step Processes FOR Surface Treatment OF Metallic Material Involving AT Least ONE Process Provided FOR IN Class C23 AND AT Least ONE Process Covered BY Subclass C21d 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cagent Vascular, Inc.'s patent record in context - here's where to go next.

Cagent Vascular, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #12,856 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cagent Vascular, Inc. against Creighton University, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.